Saturday, October 31, 2026

GBP/EUR Bullish By 1% In The Last 10 Sessions

GBP/EUR Bullish By 1% In The Last 10 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 1.01% for the last 10 sessions. At 10:07 EST on Tuesday, 6 June, GBP/EUR (GBPEUR) is $1.16.

GBP/EUR's yearly highs and lows, it's 7.426% up from its 52-week low and 3.111% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was 0.13%, 0.08%, and 0.25%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.24% (last week), 0.21% (last month), and 0.25% (last quarter), respectively.

News about

  • Usd/jpy price analysis: ready to fly above 140.40 as upbeat US NFP accelerates hawkish fed bets. According to FXStreet on Monday, 5 June, "The USD/JPY pair has shifted its auction comfortably above the crucial resistance of 140.00 in the Asian session. "
  • Usd/jpy sits near multi-day peak, around 140.25-30 area amid stronger USD. According to FXStreet on Monday, 5 June, "The fundamental backdrop, however, suggests that the path of least resistance for the USD/JPY pair is to the upside. ", "Apart from this, the prevalent risk-on mood - as depicted by a generally positive tone around the equity markets - further dents the JPY's relative safe-haven status and lends additional support to the USD/JPY pair. "
  • Usd/jpy bulls trace firmer yields above 140.00, US pmis, Japan GDP eyed. According to FXStreet on Monday, 5 June, "Although the USD/JPY bears remain off the table beyond the previous resistance line stretched from December 15, 2022, around 137.40 by the press time, an ascending trend line from late 2022, close to 141.20 by the press time, challenges the Yen pair's short-term upside.", "It's worth noting, however, that the hawkish concerns about the Bank of Japan (BoJ) officials and optimism about the US debt ceiling deal, as well as US credit rating, prod the USD/JPY bulls. "
  • Usd/jpy bears eye 139.00 as Japan real wages tease boj hawks, yields ease. According to FXStreet on Tuesday, 6 June, "Apart from the data, Monday's chatters about the Japanese government's likely intervention to defend the domestic currency also weigh on the USD/JPY pair. ", "Looking ahead, a lack of major data/events can keep the USD/JPY pair vulnerable to the risk catalysts for clear directions."

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com